GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,६५५.००
arrow_downward
-०.६६%(-१७.६०) 1D
नोभेम्बर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹ २,६७३.००
High
₹ २,६८५.८०
Low
₹ २,६३६.५०
Mkt. cap
४.४७ खरब
Avg. vol.
८७.७७ हजार
Volume
९४.०७ हजार
Dividend
२.१५%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.२३
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,६७३.००
High
₹ २,६८५.८०
Low
₹ २,६३६.५०
Mkt. cap
४.४७ खरब
Avg. vol.
८७.७७ हजार
Volume
९४.०७ हजार
Dividend
२.१५%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.२३
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Bloomberg.com
·
१ घण्टा पहिले
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
RealMoney Pro
·
१ घण्टा पहिले
AI Stocks Drag the S&P 500 Back Toward the November 5th Lows
Investing.com
·
२ घण्टा पहिले
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
४७ मिनेट पहिले
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com